NCT03655288View on ClinicalTrials.gov

A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

May 31, 2023

Study Completion Date

November 30, 2023

Conditions
Hypertension
Trial Locations (1)

Unknown

RECRUITING

Inha University Hospital, Incheon

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03655288 - A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus. | Biotech Hunter | Biotech Hunter